Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk

Breast Cancer Research

Volumn 14, Issue 4, 2012, Pages

  Matise, Lauren A ^a   Palmer, Trenis D ^b   Ashby, William J ^b   Nashabi, Abudi ^b   Chytil, Anna ^a   Aakre, Mary ^a   Pickup, Michael W ^a   Gorska, Agnieszka E ^a   Zijlstra, Andries ^a,b   Moses, Harold L ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 2; DSC2 PROTEIN; GLYCOPROTEIN; GNG11 PROTEIN; MEMBRANE PROTEIN; NUCLEOTIDE BINDING PROTEIN; OSTEOGENIC PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 4; TMEFF1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TSPAN13 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VCAN PROTEIN; VIMENTIN; CADHERIN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL INVASION; CELL MIGRATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; DISEASE COURSE; FIBROBLAST; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOSS; IMMUNOBLOTTING; KNOCKOUT GENE; LASER CAPTURE MICRODISSECTION; METASTASIS; MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION; XENOGRAFT; ANIMAL; CELL COMMUNICATION; CELL JUNCTION; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CADHERINS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; INTERCELLULAR JUNCTIONS; MICE; NEOPLASMS; PHENOTYPE; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863104141     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3217     Document Type: Article

References (54)

1. Akhurst RJ, Derynck R. TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol 2001, 11:S44-S51.
2. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001, 29:117-129. 10.1038/ng1001-117, 11586292.
3. Bierie B, Moses HL. TGF-beta and cancer. Cytokine Growth Factor Rev 2006, 17:29-40. 10.1016/j.cytogfr.2005.09.006, 16289860.
4. Bierie B, Moses HL. Tumour microenvironment: TGF-β: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006, 6:506-520. 10.1038/nrc1926, 16794634.
5. Levy L, Hill CS. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006, 17:41-58. 10.1016/j.cytogfr.2005.09.009, 16310402.
6. Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD, Page DL. Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology 2000, 36:168-177. 10.1046/j.1365-2559.2000.00841.x, 10672063.
7. Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 2007, 67:11517-11527. 10.1158/0008-5472.CAN-07-1284, 18089780.
8. Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol 2003, 163:1539-1549. 10.1016/S0002-9440(10)63510-9, 1868288, 14507660.
9. Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci USA 2003, 100:8430-8435. 10.1073/pnas.0932636100, 166246, 12808151.
10. Muraoka-Cook RS, Shin I, Yi JY, Easterly E, Barcellos-Hoff MH, Yingling JM, Zent R, Arteaga CL. Activated type I TGF-β receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene 2006, 25:3408-3423. 10.1038/sj.onc.1208964, 16186809.
11. Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA, Arteaga CL. Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res 2004, 64:9002-9011. 10.1158/0008-5472.CAN-04-2111, 15604265.
12. Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 2005, 65:2296-2302. 10.1158/0008-5472.CAN-04-3272, 15781643.
13. Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 2008, 68:1809-1819. 10.1158/0008-5472.CAN-07-5597, 18339861.
14. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337. 10.1038/nature03096, 3050735, 15549095.
15. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303:848-851. 10.1126/science.1090922, 14764882.
16. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 2005, 24:5053-5068. 10.1038/sj.onc.1208685, 3074577, 15856015.
17. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007, 9:1392-1400. 10.1038/ncb1658, 18037882.
18. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGF-β signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009, 11:1287-1296. 10.1038/ncb1973, 2773241, 19838175.
19. Matise LA, Pickup MW, Moses HL. TGF-beta helps cells fly solo. Nat Cell Biol 2009, 11:1281-1284. 10.1038/ncb1109-1281, 19838176.
20. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374. 10.1038/nrc1075, 12724734.
21. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007, 9:893-904. 10.1038/ncb1616, 17618273.
22. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009, 10:445-457. 10.1038/nrm2720, 19546857.
23. Revenu C, Gilmour D. EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Dev 2009, 19:338-342. 10.1016/j.gde.2009.04.007, 19464162.
24. van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 2011, 728:23-34. 10.1016/j.mrrev.2011.05.002, 21605699.
25. Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, Hochman T, Formenti SC, Schneider RJ. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol 2009, 11:903-908. 10.1038/ncb1900, 19525934.
26. Florentine BFJ. Fine-needle aspiration cytology of the breast. Breast Care: A Clinical Guidebook for Women's Primary Health Care Providers 1999, 109-123. New York: Springer-Verlag, Hindle W.
27. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6000; discussion 6000-6001. 10.1158/0008-5472.CAN-05-0699, 16024596.
28. Yang EY, Moses HL. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990, 111:731-741. 10.1083/jcb.111.2.731, 2116177, 1696268.
29. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001, 12:27-36. 30565, 11160820.
30. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774. 10.1038/sj.onc.1208927, 16123809.
31. Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP. The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 2008, 13:221-234. 10.1016/j.ccr.2008.01.031, 3068919, 18328426.
32. Eskola J. Cell transplantation into immunodeficient chicken embryos. Reconstituting capacity of cells from the yolk sac at different stages of development and from the liver, thymus, bursa of Fabricius, spleen and bone marrow of 15-day embryos. Immunology 1977, 32:467-474. 1445470, 24586.
33. Stern CD. The chick; a great model system becomes even greater. Dev Cell 2005, 8:9-17.
34. Palmer TD, Lewis J, Zijlstra A. Quantitative analysis of cancer metastasis using an avian embryo model. J Vis Exp 2011,
35. Zijlstra A, Mellor R, Panzarella G, Aimes RT, Hooper JD, Marchenko ND, Quigley JP. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res 2002, 62:7083-7092.
36. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
37. Xi Q, He W, Zhang XH, Le HV, Massague J. Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem 2008, 283:1146-1155. 10.1074/jbc.M707479200, 2692279, 18003620.
38. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 2008, 14:570-581. 10.1016/j.devcel.2008.03.003, 2773823, 18410732.
39. Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, Leitinger B, Sahai E. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol 2011, 13:49-58. 10.1038/ncb2133, 3018349, 21170030.
40. Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, Mizoguchi A, Kasuga M, Sakamoto C. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 1999, 266:593-602. 10.1006/bbrc.1999.1873, 10600548.
41. Harms PW, Chang C. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Genes Dev 2003, 17:2624-2629. 10.1101/gad.1127703, 280611, 14563676.
42. Qi CF, Liscia DS, Normanno N, Merlo G, Johnson GR, Gullick WJ, Ciardiello F, Saeki T, Brandt R, Kim N, Kenney N, Salomon DS. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. Br J Cancer 1994, 69:903-910. 10.1038/bjc.1994.174, 1968887, 8180021.
43. Panico L, D'Antonio A, Salvatore G, Mezza E, Tortora G, De Laurentiis M, De Placido S, Giordano T, Merino M, Salomon DS, Mullick WJ, Pettinato G, Schnitt SJ, Bianco AR, Ciardiello F. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer 1996, 65:51-56. 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0, 8543395.
44. Oshimori N, Fuchs E. Paracrine TGF-beta signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. Cell Stem Cell 2012, 10:63-75. 10.1016/j.stem.2011.11.005, 3349223, 22226356.
45. Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007, 98:1512-1520. 10.1111/j.1349-7006.2007.00550.x, 17645776.
46. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010, 15:117-134. 10.1007/s10911-010-9178-9, 2886089, 20490631.
47. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006, 66:8319-8326. 10.1158/0008-5472.CAN-06-0410, 16951136.
48. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGF-β signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009, 11:1287-1296. 10.1038/ncb1973, 2773241, 19838175.
49. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454. 10.1038/nrc822, 12189386.
50. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-383. 10.1002/jcp.21223, 17680632.
51. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981. 10.1083/jcb.200601018, 2063755, 16567498.
52. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001, 98:10356-10361. 10.1073/pnas.171610498, 56965, 11526241.
53. Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 2009, 69:7135-7139. 10.1158/0008-5472.CAN-09-1618, 2760965, 19738043.
54. Xu BJ, Yan W, Jovanovic B, An AQ, Cheng N, Aakre ME, Yi Y, Eng J, Link AJ, Moses HL. Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts. Proteomics 2010, 10:2458-2470. 10.1002/pmic.200900701, 20405477.